Legal status · United States
Is Kisspeptin-54 legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Kisspeptin-54 is not approved for any medical use in the United States; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. On the evidence, 5 human studies are cited on its profile.
Kisspeptin-54 in the United States at a glance
| Classification | Investigational, not approved |
|---|---|
| Note | No approved product. The published human trials are investigator-led phase 2 studies run in the United Kingdom. |
| FDA approval status | Investigational. No approved kisspeptin product exists in any jurisdiction. The IVF trigger work is phase 2 and has not been taken to a registrational phase 3 programme. |
| Human studies cited | 5 of 6 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Kisspeptin-54 profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
Kisspeptin-54 is being studied in registered clinical trials but has not received FDA marketing approval in the United States.
- 02
Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.
- 03
Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.
What Kisspeptin-54 is
Genuinely good randomised human evidence, all of it about triggering egg maturation in IVF: oocyte maturation in 95% of 60 women at high risk of ovarian hyperstimulation syndrome, with no moderate, severe or critical cases. Chronic dosing causes tachyphylaxis, a randomised trial found no effect on anxiety, and chronic subcutaneous dosing caused testicular degeneration in adult male rats.
Kisspeptin-54 is one of the better-evidenced compounds on this site, and the evidence points somewhere very specific that has almost nothing to do with how it is sold. It is the 54 residue product of the KISS1 gene, acting at KISS1R upstream of GnRH neurons.
Mechanism: Demonstrated in humans, not proposed. Kisspeptin-54 binds KISS1R, formerly GPR54, on hypothalamic GnRH neurons, triggering release of an endogenous pool of GnRH, which drives pituitary luteinising hormone and follicle-stimulating hormone secretion.
Regulatory history: Investigational. No approved kisspeptin product exists in any jurisdiction. The IVF trigger work is phase 2 and has not been taken to a registrational phase 3 programme.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Kisspeptin-54 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Kisspeptin-54 in other countries
Frequently asked questions
Is Kisspeptin-54 legal in the United States?
No. Kisspeptin-54 is not approved for any medical use in the United States; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. On the evidence, 5 human studies are cited on its profile. Note: No approved product. The published human trials are investigator-led phase 2 studies run in the United Kingdom.
Can I buy Kisspeptin-54 in the United States?
No approved product exists to buy. In the United States Kisspeptin-54 is classified as "Investigational, not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: No approved product. The published human trials are investigator-led phase 2 studies run in the United Kingdom.
Is Kisspeptin-54 FDA approved?
No. FDA status: Investigational. No approved kisspeptin product exists in any jurisdiction. The IVF trigger work is phase 2 and has not been taken to a registrational phase 3 programme.. Current US classification: "Investigational, not approved". On the evidence, 5 human studies are cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Kisspeptin-54 live on its compound profile.
Kisspeptin-54 profileThis page is general information about the regulatory status of Kisspeptin-54 in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.